Venture Med Group develops medical devices for vascular health, focusing on peripheral artery disease and arteriovenous access treatment.
Venture Med Group has raised $28.0M in total funding. The most recent round was Series C. The last funding was announced in October 2025.
Venture Med Group's investors include S3 Ventures, RiverVest, Endeavour Vision, Rocket Ventures.
Venture Med Group is headquartered in Plymouth, United States.
Venture Med Group develops medical devices for vascular health, focusing on peripheral artery disease and arteriovenous access treatment.
Venture Med Group is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Venture Med Group — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/venture-med-group. Accessed October 30, 2026.
VCBacked. (2025). Venture Med Group — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/venture-med-group
{{cite web |title=Venture Med Group — Funding & Investors |url=https://www.vcbacked.co/company/venture-med-group |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated